BioCardia, Inc. (BCDA) vs Vyome Holdings, Inc. (HIND)
- BioCardia, Inc. BCDA 0.92 −2.13%
- Vyome Holdings, Inc. HIND 1.87 −2.09%
BioCardia, Inc. and Vyome Holdings, Inc. are both Biotechnology companies. BioCardia, Inc. and Vyome Holdings, Inc. are of similar size ($14.2M and $13.4M). BioCardia, Inc. has negative trailing earnings, so its P/E is not meaningful; Vyome Holdings, Inc. trades at 0.0×. Vyome Holdings, Inc. grew revenue faster over the last twelve months: 103.8% against 0.71%. BioCardia, Inc. has the higher net margin (0.00% vs −8,711.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, BioCardia, Inc. leads on 8 and Vyome Holdings, Inc. on 8.
Valuation
Profitability
| Metric | BCDA | HIND | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 52.77% | 65.16% |
| Operating margin | 0.00% | (9,184.82%) | 0.00% |
| Net margin | 0.00% | (8,711.71%) | 0.00% |
| Free cash flow margin | 0.00% | (4,298.00%) | 0.00% |
| Return on equity | (1,803.19%) | (172.10%) | (56.36%) |
| Return on assets | (214.47%) | (124.23%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack